CarpenterCF, ChambersHF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis2004;38:994–1000.
2.
SegretiJA, CrankCW, FinneyMS. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy2006;26:347–52.
3.
LeeBL, SachdevaM, ChambersHF. Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrob Agents Chemother1991;35:2505–8.
SafdarN, AndesD, CraigWA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother2004;48:63–8.
6.
MichielsMJ, BergeronMG. Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration. Antimicrob Agents Chemother1996;40:203–11.
